Exogenous insulin was recommenced on day 660 due to the development of type 2 diabetes-like changes, possibly related to weight gain over the course of the experiment (from 10.7 kg to 18.1 kg, Figure 5). Here, INS is linked to type 2 diabetes mellitus.